Sulfuric Acid

Sulfuric Acid

SCHEMBL9955552

O=S(=O)(O)O.c1cscn1

nearest known ligand 0.32

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CA5A P35218 1/20 0.32
CA5B Q9Y2D0 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109503344-A One kind is ionic liquid-catalyzed to prepare benzoic method 浙江昊唐实业有限公司 2019-03-22 CN claimed
EP-3166981-B1 OLIGOSACCHARIDE COMPOSITIONS AND METHODS FOR PRODUCING THEREOF DSM NUTRITIONAL PRODUCTS LLC (US) 2026-05-13 EP disclosed
US-12514267-B2 Oligosaccharide compositions for use as animal feed and methods of producing thereof DSM NUTRITIONAL PRODUCTS, LLC (US) 2026-01-06 US disclosed
US-20250057202-A1 OLIGOSACCHARIDE COMPOSITIONS FOR USE AS FOOD INGREDIENTS AND METHODS OF PRODUCING THEREOF DSM NUTRITIONAL PRODUCTS LLC (US) 2025-02-20 US disclosed
US-20230255240-A1 OLIGOSACCHARIDE COMPOSITIONS FOR USE AS ANIMAL FEED AND METHODS OF PRODUCING THEREOF MIDORI USA, INC. 2023-08-17 US disclosed
EP-4205553-A1 OLIGOSACCHARIDE COMPOSITIONS FOR USE ANIMAL FEED AND METHODS OF PRODUCING THEREOF DSM Nutritional Products, LLC (US) 2023-07-05 EP disclosed
US-11653676-B2 Oligosaccharide compositions for use as animal feed and methods of producing thereof DSM NUTRITIONAL PRODUCTS, LLC (US) 2023-05-23 US disclosed
CN-115974864-A Synthetic method of 2- (3-azetidinyl) thiazole salt 苏州汉德创宏生化科技有限公司 2023-04-18 CN disclosed
US-11584805-B2 Oligosaccharide compositions and methods for producing thereof DSM NUTRITIONAL PRODUCTS, LLC (US) 2023-02-21 US disclosed
US-20220409644-A1 ANIMAL THERAPEUTIC AND FEED COMPOSITIONS AND METHODS OF USE DSM NUTRITIONAL PRODUCTS, LLC 2022-12-29 US disclosed
US-9394426-B2 Vegetable oil derivatives as extender oils for elastomer compositions NOVAMONT S.P.A. (IT) 2016-07-19 US disclosed
EP-2963084-A1 Vegetable oil derivatives as extender oils for elastomer compositions NOVAMONT S.p.A. (IT) 2016-01-06 EP disclosed
EP-2655500-B1 VEGETABLE OIL DERIVATIVES AS EXTENDER OILS FOR ELASTOMER COMPOSITIONS. NOVAMONT SPA (IT) 2015-09-23 EP disclosed
US-20150158993-A1 VEGETABLE OIL DERIVATIVES AS EXTENDER OILS FOR ELASTOMER COMPOSITIONS NOVAMONT SPA (IT) 2015-06-11 US disclosed
US-8969454-B2 Vegetable oil derivatives as extender oils for elastomer compositions NOVAMONT S.P.A. (IT) 2015-03-03 US disclosed
US-20130289182-A1 VEGETABLE OIL DERIVATIVES AS EXTENDER OILS FOR ELASTOMER COMPOSITIONS NOVAMONT S.P.A. (IT) 2013-10-31 US disclosed
EP-2655500-A1 VEGETABLE OIL DERIVATIVES AS EXTENDER OILS FOR ELASTOMER COMPOSITIONS. Novamont S.p.A. (IT) 2013-10-30 EP disclosed
CN-101980643-B Temperature-stabilized medicinal storage systems TOKITAE LLC 2013-07-24 CN disclosed
WO-2012085014-A1 VEGETABLE OIL DERIVATIVES AS EXTENDER OILS FOR ELASTOMER COMPOSITIONS. NOVAMONT S.P.A. (IT) 2012-06-28 WO disclosed
CN-101980643-A Temperature-stabilized medicinal storage systems SEARETE LLC 2011-02-23 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230255240-A1 OLIGOSACCHARIDE COMPOSITIONS FOR USE AS ANIMAL FEED AND METHODS OF PRODUCING THEREOF FUT5, FUT6, OSTC CA5A 2542/4885CA5B 3093/4885
US-11584805-B2 Oligosaccharide compositions and methods for producing thereof OSTC, FUT5, FUT6 CA5A 760/4885CA5B 824/4885
US-11653676-B2 Oligosaccharide compositions for use as animal feed and methods of producing thereof FUT5, FUT6, OSTC CA5A 2542/4885CA5B 3093/4885
US-20220409644-A1 ANIMAL THERAPEUTIC AND FEED COMPOSITIONS AND METHODS OF USE FUT6, FUT5, PIGS CA5A 3839/4885CA5B 3992/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.